1. Home
  2. CDW vs BNTX Comparison

CDW vs BNTX Comparison

Compare CDW & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CDW Corporation

CDW

CDW Corporation

HOLD

Current Price

$139.29

Market Cap

18.9B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$95.46

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDW
BNTX
Founded
1984
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9B
24.8B
IPO Year
1993
2019

Fundamental Metrics

Financial Performance
Metric
CDW
BNTX
Price
$139.29
$95.46
Analyst Decision
Buy
Buy
Analyst Count
8
11
Target Price
$185.13
$137.40
AVG Volume (30 Days)
1.9M
1.6M
Earning Date
02-04-2026
11-03-2025
Dividend Yield
1.82%
N/A
EPS Growth
N/A
N/A
EPS
7.91
N/A
Revenue
$22,099,100,000.00
$3,698,814,972.00
Revenue This Year
$6.77
$2.03
Revenue Next Year
$2.85
N/A
P/E Ratio
$17.54
N/A
Revenue Growth
6.09
3.70
52 Week Low
$135.63
$81.20
52 Week High
$222.92
$129.27

Technical Indicators

Market Signals
Indicator
CDW
BNTX
Relative Strength Index (RSI) 36.61 45.60
Support Level $138.37 $91.32
Resistance Level $146.15 $93.76
Average True Range (ATR) 3.65 2.09
MACD -0.62 0.18
Stochastic Oscillator 7.25 46.39

Price Performance

Historical Comparison
CDW
BNTX

About CDW CDW Corporation

CDW Corp is a multi-brand provider of information technology ("IT") solutions to small, medium, and large business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's broad array of offerings ranges from discrete hardware and software products to integrated IT solutions and services that include on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. The company has five operating segments namely, Corporate, Small Business, Public, CDW UK, and CDW Canada. The Corporate segment generates the majority of its revenue and serves USA private sector business customers.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: